Objective Measurement of Adherence to Out-Patient Airway Clearance Therapy by High-Frequency Chest Wall Compression in Cystic Fibrosis

被引:14
|
作者
Mikesell, Christina L. [1 ,2 ,3 ]
Kempainen, Robert R. [4 ,5 ]
Laguna, Theresa A. [2 ,3 ]
Menk, Jeremiah S. [6 ]
Wey, Andrew R. [6 ]
Gaillard, Philippe R. [7 ]
Regelmann, Warren E. [2 ,3 ]
机构
[1] Childrens Resp & Crit Care Specialists, Minneapolis, MN USA
[2] Univ Minnesota, Cyst Fibrosis Ctr, Pediat Pulmonol, Minneapolis, MN USA
[3] Masonic Childrens Hosp, Minneapolis, MN USA
[4] Hennepin Cty Med Ctr, Pulm & Crit Care Med, Minneapolis, MN USA
[5] Univ Minnesota, Cyst Fibrosis Ctr & Hosp, Minneapolis, MN USA
[6] Univ Minnesota, Clin & Translat Sci Inst, Minneapolis, MN USA
[7] Auburn Univ, Dept Math & Stat, Auburn, AL 36849 USA
关键词
adherence; cystic fibrosis; high-frequency chest wall compression; pulmonary function test; pulmonary exacerbation; PULMONARY EXACERBATIONS; MEDICATION ADHERENCE; SELF-REPORT; CHILDREN; ADULTS; ADOLESCENTS; HEALTH;
D O I
10.4187/respcare.05349
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Objective measures of adherence to high-frequency chest wall compression (HFCWC), a form of airway clearance therapy for patients with cystic fibrosis, are lacking. We used a novel electronic monitoring device integrated into an HFCWC vest to measure adherence compared with self-reported adherence. We determined factors that influenced adherence and how adherence correlated with baseline pulmonary function and pulmonary exacerbations. METHODS: Data were collected by direct measurement of date, time of day, and duration of HFCWC use to determine the number of daily treatments and daily duration of treatments. Chart review provided prescribed airway clearance therapy treatment and demographic and clinical information. Subject and caregiver report of the daily number of airway clearance therapy treatments was obtained by telephone interviews. Analysis used 2-sample and paired t test, analysis of variance, and linear regression. RESULTS: Average adherence was 69%. Adherence was highest in children (82%, P = .02) and those receiving assistance with treatment (82%, P < .001). Subjects overestimated therapy duration from a mean +/- SD of 127 +/- 169% by adults to 19.2 +/- 26.3% by parents or guardians of children. Average adherence decreased with increasing prescribed therapy time (P = .02). Average daily therapy time and adherence had significant positive associations with baseline FEV1 percent of predicted (P = .02 and P = .02, respectively) and negative associations with pulmonary exacerbations during the pre-study period and at baseline (P = .044 and P = .02, respectively). CONCLUSIONS: Greater adherence to HFCWC measured directly by a novel recorder was associated with better baseline pulmonary function and fewer exacerbations in the pre-study and baseline period. Adherence decreased with age and prescribed therapy time and increased with therapy assistance. Self-report overestimation is large and thus not an accurate measure of adherence.
引用
下载
收藏
页码:920 / 927
页数:8
相关论文
共 50 条
  • [1] Comparison of high-frequency chest wall oscillation with differing waveforms for airway clearance in cystic fibrosis
    Kempainen, Robert R.
    Williams, Cynthia B.
    Hazelwood, Ann
    Rubin, Bruce K.
    Milla, Carlos E.
    CHEST, 2007, 132 (04) : 1227 - 1232
  • [2] AIRWAY CLEARANCE BY HIGH-FREQUENCY CHEST COMPRESSION
    WARWICK, WJ
    MARZOTTO, A
    PEDIATRIC PULMONOLOGY, 1992, : 138 - 139
  • [3] HIGH-FREQUENCY CHEST WALL OSCILLATION IN CYSTIC FIBROSIS: AN INVESTIGATION INTO ADHERENCE AND THE RELIABILITY OF PATIENT REPORTING
    Mikesell, C. L.
    Kempainen, R.
    Laguna, T. A.
    Henn, L.
    Gaillard, P.
    Hazelwood, A.
    Williams, C.
    Regelmann, W.
    PEDIATRIC PULMONOLOGY, 2011, : 414 - 414
  • [4] High-Frequency Chest Wall Oscillation In Cystic Fibrosis: An Investigation Into Adherence And The Reliability Of Patient Reporting
    Mikesell, C. L.
    Regelmann, W. E.
    Gaillard, P.
    Henn, L.
    Hazelwood, A.
    Williams, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [5] Comparison of Settings Used for High-Frequency Chest-Wall Compression in Cystic Fibrosis
    Kempainen, Robert R.
    Milla, Carlos
    Dunitz, Jordan
    Savik, Kay
    Hazelwood, Ann
    Williams, Cynthia
    Rubin, Bruce K.
    Billings, Joanne L.
    RESPIRATORY CARE, 2010, 55 (06) : 695 - 701
  • [6] ENHANCED MUCUS CLEARANCE WITH HIGH-FREQUENCY CHEST WALL COMPRESSION
    KING, M
    PHILLIPS, D
    GROSS, D
    VARTIAN, V
    CHANG, HK
    ZIDULKA, A
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1983, 127 (04): : 166 - 166
  • [7] PERIPHERAL MUCOCILIARY CLEARANCE WITH HIGH-FREQUENCY CHEST WALL COMPRESSION
    GROSS, D
    ZIDULKA, A
    OBRIEN, C
    WIGHT, D
    FRASER, R
    ROSENTHAL, L
    KING, M
    JOURNAL OF APPLIED PHYSIOLOGY, 1985, 58 (04) : 1157 - 1163
  • [8] Effect of high-frequency oral airway and chest wall oscillation and conventional chest physical therapy on expectoration in patients with stable cystic fibrosis
    Scherer, TA
    Barandun, J
    Martinez, E
    Wanner, A
    Rubin, EM
    CHEST, 1998, 113 (04) : 1019 - 1027
  • [9] Objective Versus Self-Reported Adherence to Airway Clearance Therapy in Cystic Fibrosis
    Oates, Gabriela R.
    Stepanikova, Irena
    Rowe, Steven M.
    Gamble, Stephanie
    Gutierrez, Hector H.
    Harris, William T.
    RESPIRATORY CARE, 2019, 64 (02) : 176 - 181
  • [10] ENHANCED TRACHEAL MUCUS CLEARANCE WITH HIGH-FREQUENCY CHEST WALL COMPRESSION
    KING, M
    PHILLIPS, DM
    GROSS, D
    VARTIAN, V
    CHANG, HK
    ZIDULKA, A
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1983, 128 (03): : 511 - 515